nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2B6—Thiotepa—urinary bladder cancer	0.157	0.312	CbGbCtD
Promethazine—ABCB1—Mitomycin—urinary bladder cancer	0.107	0.211	CbGbCtD
Promethazine—CYP2B6—Cisplatin—urinary bladder cancer	0.0434	0.0861	CbGbCtD
Promethazine—ABCB1—Gemcitabine—urinary bladder cancer	0.0307	0.0607	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0291	0.0577	CbGbCtD
Promethazine—CYP2C9—Fluorouracil—urinary bladder cancer	0.027	0.0535	CbGbCtD
Promethazine—CYP2C9—Cisplatin—urinary bladder cancer	0.023	0.0455	CbGbCtD
Promethazine—ABCB1—Cisplatin—urinary bladder cancer	0.0223	0.0441	CbGbCtD
Promethazine—ABCB1—Etoposide—urinary bladder cancer	0.0219	0.0434	CbGbCtD
Promethazine—CHRM3—ureter—urinary bladder cancer	0.0205	0.155	CbGeAlD
Promethazine—ABCB1—Doxorubicin—urinary bladder cancer	0.0149	0.0296	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0148	0.112	CbGeAlD
Promethazine—ABCB1—Methotrexate—urinary bladder cancer	0.0145	0.0286	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0141	0.0279	CbGbCtD
Promethazine—CYP2C9—urine—urinary bladder cancer	0.0048	0.0363	CbGeAlD
Promethazine—HTR2A—urine—urinary bladder cancer	0.00395	0.0299	CbGeAlD
Promethazine—CYP2D6—urine—urinary bladder cancer	0.0036	0.0272	CbGeAlD
Promethazine—CHRM5—epithelium—urinary bladder cancer	0.00314	0.0237	CbGeAlD
Promethazine—CALM3—prostate gland—urinary bladder cancer	0.00298	0.0225	CbGeAlD
Promethazine—CHRM2—prostate gland—urinary bladder cancer	0.00294	0.0222	CbGeAlD
Promethazine—CHRM1—prostate gland—urinary bladder cancer	0.00267	0.0202	CbGeAlD
Promethazine—CALM3—seminal vesicle—urinary bladder cancer	0.00252	0.019	CbGeAlD
Promethazine—CHRM3—prostate gland—urinary bladder cancer	0.00239	0.0181	CbGeAlD
Promethazine—CALM2—prostate gland—urinary bladder cancer	0.00234	0.0177	CbGeAlD
Promethazine—CALM1—prostate gland—urinary bladder cancer	0.00233	0.0176	CbGeAlD
Promethazine—ADRA1A—prostate gland—urinary bladder cancer	0.0022	0.0166	CbGeAlD
Promethazine—CALM3—smooth muscle tissue—urinary bladder cancer	0.00211	0.0159	CbGeAlD
Promethazine—CALM3—urethra—urinary bladder cancer	0.002	0.0151	CbGeAlD
Promethazine—CALM2—seminal vesicle—urinary bladder cancer	0.00198	0.015	CbGeAlD
Promethazine—CALM2—epithelium—urinary bladder cancer	0.00172	0.013	CbGeAlD
Promethazine—CALM1—epithelium—urinary bladder cancer	0.00171	0.0129	CbGeAlD
Promethazine—HRH1—prostate gland—urinary bladder cancer	0.0017	0.0128	CbGeAlD
Promethazine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00169	0.0128	CbGeAlD
Promethazine—CALM2—smooth muscle tissue—urinary bladder cancer	0.00166	0.0125	CbGeAlD
Promethazine—CALM1—smooth muscle tissue—urinary bladder cancer	0.00165	0.0125	CbGeAlD
Promethazine—CHRM3—renal system—urinary bladder cancer	0.00163	0.0123	CbGeAlD
Promethazine—ADRA1A—epithelium—urinary bladder cancer	0.00161	0.0122	CbGeAlD
Promethazine—CHRM3—urethra—urinary bladder cancer	0.0016	0.0121	CbGeAlD
Promethazine—CALM2—renal system—urinary bladder cancer	0.0016	0.0121	CbGeAlD
Promethazine—CALM1—renal system—urinary bladder cancer	0.00159	0.012	CbGeAlD
Promethazine—Benzphetamine—POR—urinary bladder cancer	0.00157	0.448	CrCbGaD
Promethazine—CALM2—urethra—urinary bladder cancer	0.00157	0.0118	CbGeAlD
Promethazine—CALM1—urethra—urinary bladder cancer	0.00156	0.0118	CbGeAlD
Promethazine—ADRA1A—renal system—urinary bladder cancer	0.0015	0.0113	CbGeAlD
Promethazine—CALM3—vagina—urinary bladder cancer	0.00147	0.0111	CbGeAlD
Promethazine—CHRM1—female reproductive system—urinary bladder cancer	0.00146	0.011	CbGeAlD
Promethazine—Carbamazepine—UGT2B7—urinary bladder cancer	0.00135	0.384	CrCbGaD
Promethazine—CHRM3—female reproductive system—urinary bladder cancer	0.00131	0.00986	CbGeAlD
Promethazine—CALM2—female reproductive system—urinary bladder cancer	0.00128	0.00965	CbGeAlD
Promethazine—CALM1—female reproductive system—urinary bladder cancer	0.00127	0.00961	CbGeAlD
Promethazine—HRH1—epithelium—urinary bladder cancer	0.00125	0.00944	CbGeAlD
Promethazine—HRH1—smooth muscle tissue—urinary bladder cancer	0.0012	0.00909	CbGeAlD
Promethazine—CYP2B6—renal system—urinary bladder cancer	0.00119	0.00896	CbGeAlD
Promethazine—CALM2—vagina—urinary bladder cancer	0.00116	0.00873	CbGeAlD
Promethazine—CALM1—vagina—urinary bladder cancer	0.00115	0.00869	CbGeAlD
Promethazine—HRH1—urethra—urinary bladder cancer	0.00114	0.0086	CbGeAlD
Promethazine—HTR2A—epithelium—urinary bladder cancer	0.00104	0.00788	CbGeAlD
Promethazine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.001	0.00759	CbGeAlD
Promethazine—HTR2A—renal system—urinary bladder cancer	0.000967	0.00731	CbGeAlD
Promethazine—CALM3—lymph node—urinary bladder cancer	0.000952	0.00719	CbGeAlD
Promethazine—CYP2B6—female reproductive system—urinary bladder cancer	0.00095	0.00718	CbGeAlD
Promethazine—CYP2C9—female reproductive system—urinary bladder cancer	0.000941	0.00711	CbGeAlD
Promethazine—ABCB1—prostate gland—urinary bladder cancer	0.00093	0.00703	CbGeAlD
Promethazine—HRH1—female reproductive system—urinary bladder cancer	0.000928	0.00701	CbGeAlD
Promethazine—CYP2D6—renal system—urinary bladder cancer	0.000881	0.00666	CbGeAlD
Promethazine—CYP2B6—vagina—urinary bladder cancer	0.000859	0.00649	CbGeAlD
Promethazine—HRH1—vagina—urinary bladder cancer	0.000839	0.00634	CbGeAlD
Promethazine—ABCB1—seminal vesicle—urinary bladder cancer	0.000787	0.00594	CbGeAlD
Promethazine—HTR2A—female reproductive system—urinary bladder cancer	0.000775	0.00585	CbGeAlD
Promethazine—CALM2—lymph node—urinary bladder cancer	0.000747	0.00565	CbGeAlD
Promethazine—CALM1—lymph node—urinary bladder cancer	0.000744	0.00562	CbGeAlD
Promethazine—CYP2D6—female reproductive system—urinary bladder cancer	0.000706	0.00533	CbGeAlD
Promethazine—HTR2A—vagina—urinary bladder cancer	0.000701	0.00529	CbGeAlD
Promethazine—ABCB1—epithelium—urinary bladder cancer	0.000683	0.00516	CbGeAlD
Promethazine—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000673	0.00288	CcSEcCtD
Promethazine—Vision blurred—Thiotepa—urinary bladder cancer	0.000654	0.0028	CcSEcCtD
Promethazine—Coordination abnormal—Epirubicin—urinary bladder cancer	0.000651	0.00279	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000641	0.00275	CcSEcCtD
Promethazine—Agitation—Thiotepa—urinary bladder cancer	0.000638	0.00273	CcSEcCtD
Promethazine—Bradycardia—Cisplatin—urinary bladder cancer	0.000636	0.00272	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—urinary bladder cancer	0.000635	0.00272	CcSEcCtD
Promethazine—ABCB1—renal system—urinary bladder cancer	0.000634	0.00479	CbGeAlD
Promethazine—Dermatitis contact—Epirubicin—urinary bladder cancer	0.000632	0.00271	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.000629	0.0027	CcSEcCtD
Promethazine—Coma—Methotrexate—urinary bladder cancer	0.000624	0.00267	CcSEcCtD
Promethazine—ABCB1—urethra—urinary bladder cancer	0.000623	0.00471	CbGeAlD
Promethazine—Jaundice—Etoposide—urinary bladder cancer	0.000622	0.00266	CcSEcCtD
Promethazine—Leukopenia—Thiotepa—urinary bladder cancer	0.000621	0.00266	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—urinary bladder cancer	0.000602	0.00258	CcSEcCtD
Promethazine—Convulsion—Thiotepa—urinary bladder cancer	0.000601	0.00257	CcSEcCtD
Promethazine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.0006	0.00257	CcSEcCtD
Promethazine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000599	0.00257	CcSEcCtD
Promethazine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000595	0.00255	CcSEcCtD
Promethazine—Clomipramine—GSTP1—urinary bladder cancer	0.000593	0.169	CrCbGaD
Promethazine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000589	0.00252	CcSEcCtD
Promethazine—Anxiety—Thiotepa—urinary bladder cancer	0.000589	0.00252	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.000588	0.00252	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.000584	0.0025	CcSEcCtD
Promethazine—Coma—Epirubicin—urinary bladder cancer	0.000584	0.0025	CcSEcCtD
Promethazine—Erythema—Gemcitabine—urinary bladder cancer	0.000584	0.0025	CcSEcCtD
Promethazine—Tinnitus—Cisplatin—urinary bladder cancer	0.000583	0.0025	CcSEcCtD
Promethazine—Erythema—Fluorouracil—urinary bladder cancer	0.000574	0.00246	CcSEcCtD
Promethazine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.000573	0.00245	CcSEcCtD
Promethazine—Confusional state—Thiotepa—urinary bladder cancer	0.000571	0.00245	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—urinary bladder cancer	0.000565	0.00242	CcSEcCtD
Promethazine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000558	0.00239	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000555	0.00238	CcSEcCtD
Promethazine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000555	0.00237	CcSEcCtD
Promethazine—Tachycardia—Thiotepa—urinary bladder cancer	0.000553	0.00237	CcSEcCtD
Promethazine—Erythema—Cisplatin—urinary bladder cancer	0.000544	0.00233	CcSEcCtD
Promethazine—HRH1—lymph node—urinary bladder cancer	0.000543	0.0041	CbGeAlD
Promethazine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000541	0.00232	CcSEcCtD
Promethazine—Coma—Doxorubicin—urinary bladder cancer	0.00054	0.00231	CcSEcCtD
Promethazine—Phlebitis—Epirubicin—urinary bladder cancer	0.000539	0.00231	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000536	0.0023	CcSEcCtD
Promethazine—Photosensitivity—Epirubicin—urinary bladder cancer	0.000528	0.00226	CcSEcCtD
Promethazine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000523	0.00224	CcSEcCtD
Promethazine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000523	0.00224	CcSEcCtD
Promethazine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000514	0.0022	CcSEcCtD
Promethazine—Vision blurred—Cisplatin—urinary bladder cancer	0.000513	0.0022	CcSEcCtD
Promethazine—Tremor—Cisplatin—urinary bladder cancer	0.00051	0.00218	CcSEcCtD
Promethazine—ABCB1—female reproductive system—urinary bladder cancer	0.000508	0.00384	CbGeAlD
Promethazine—Somnolence—Thiotepa—urinary bladder cancer	0.000503	0.00216	CcSEcCtD
Promethazine—Dyspepsia—Thiotepa—urinary bladder cancer	0.000499	0.00213	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—urinary bladder cancer	0.000498	0.00213	CcSEcCtD
Promethazine—Convulsion—Fluorouracil—urinary bladder cancer	0.000497	0.00213	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000496	0.00212	CcSEcCtD
Promethazine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000492	0.00211	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.000489	0.00209	CcSEcCtD
Promethazine—Fatigue—Thiotepa—urinary bladder cancer	0.000488	0.00209	CcSEcCtD
Promethazine—Leukopenia—Cisplatin—urinary bladder cancer	0.000487	0.00209	CcSEcCtD
Promethazine—Constipation—Thiotepa—urinary bladder cancer	0.000484	0.00207	CcSEcCtD
Promethazine—Pain—Thiotepa—urinary bladder cancer	0.000484	0.00207	CcSEcCtD
Promethazine—Muscle spasms—Etoposide—urinary bladder cancer	0.000479	0.00205	CcSEcCtD
Promethazine—Oedema—Gemcitabine—urinary bladder cancer	0.000476	0.00204	CcSEcCtD
Promethazine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000476	0.00204	CcSEcCtD
Promethazine—Irritability—Methotrexate—urinary bladder cancer	0.000473	0.00203	CcSEcCtD
Promethazine—Confusional state—Fluorouracil—urinary bladder cancer	0.000472	0.00202	CcSEcCtD
Promethazine—Convulsion—Cisplatin—urinary bladder cancer	0.000471	0.00202	CcSEcCtD
Promethazine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000468	0.00201	CcSEcCtD
Promethazine—Oedema—Fluorouracil—urinary bladder cancer	0.000468	0.00201	CcSEcCtD
Promethazine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000467	0.002	CcSEcCtD
Promethazine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000466	0.002	CcSEcCtD
Promethazine—Diplopia—Epirubicin—urinary bladder cancer	0.000464	0.00199	CcSEcCtD
Promethazine—Anxiety—Cisplatin—urinary bladder cancer	0.000462	0.00198	CcSEcCtD
Promethazine—ABCB1—vagina—urinary bladder cancer	0.000459	0.00347	CbGeAlD
Promethazine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000459	0.00196	CcSEcCtD
Promethazine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000457	0.00196	CcSEcCtD
Promethazine—Leukopenia—Etoposide—urinary bladder cancer	0.000446	0.00191	CcSEcCtD
Promethazine—Hypotension—Gemcitabine—urinary bladder cancer	0.000445	0.00191	CcSEcCtD
Promethazine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000444	0.0019	CcSEcCtD
Promethazine—Oedema—Cisplatin—urinary bladder cancer	0.000444	0.0019	CcSEcCtD
Promethazine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000438	0.00188	CcSEcCtD
Promethazine—Hypotension—Fluorouracil—urinary bladder cancer	0.000438	0.00187	CcSEcCtD
Promethazine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000435	0.00186	CcSEcCtD
Promethazine—Tachycardia—Cisplatin—urinary bladder cancer	0.000433	0.00186	CcSEcCtD
Promethazine—Convulsion—Etoposide—urinary bladder cancer	0.000432	0.00185	CcSEcCtD
Promethazine—Insomnia—Gemcitabine—urinary bladder cancer	0.000431	0.00185	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—urinary bladder cancer	0.000429	0.00184	CcSEcCtD
Promethazine—Asthma—Methotrexate—urinary bladder cancer	0.000428	0.00184	CcSEcCtD
Promethazine—Insomnia—Fluorouracil—urinary bladder cancer	0.000424	0.00181	CcSEcCtD
Promethazine—Somnolence—Gemcitabine—urinary bladder cancer	0.000424	0.00181	CcSEcCtD
Promethazine—Somnolence—Fluorouracil—urinary bladder cancer	0.000416	0.00178	CcSEcCtD
Promethazine—Hypotension—Cisplatin—urinary bladder cancer	0.000415	0.00178	CcSEcCtD
Promethazine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000414	0.00177	CcSEcCtD
Promethazine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000412	0.00177	CcSEcCtD
Promethazine—Fatigue—Gemcitabine—urinary bladder cancer	0.000411	0.00176	CcSEcCtD
Promethazine—Confusional state—Etoposide—urinary bladder cancer	0.00041	0.00176	CcSEcCtD
Promethazine—Pain—Gemcitabine—urinary bladder cancer	0.000407	0.00174	CcSEcCtD
Promethazine—Constipation—Gemcitabine—urinary bladder cancer	0.000407	0.00174	CcSEcCtD
Promethazine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000407	0.00174	CcSEcCtD
Promethazine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000407	0.00174	CcSEcCtD
Promethazine—Asthenia—Thiotepa—urinary bladder cancer	0.000406	0.00174	CcSEcCtD
Promethazine—Asthma—Epirubicin—urinary bladder cancer	0.000401	0.00172	CcSEcCtD
Promethazine—Pruritus—Thiotepa—urinary bladder cancer	0.000401	0.00172	CcSEcCtD
Promethazine—Pain—Fluorouracil—urinary bladder cancer	0.000401	0.00172	CcSEcCtD
Promethazine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000398	0.00171	CcSEcCtD
Promethazine—Tachycardia—Etoposide—urinary bladder cancer	0.000397	0.0017	CcSEcCtD
Promethazine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000393	0.00168	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000391	0.00168	CcSEcCtD
Promethazine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000387	0.00166	CcSEcCtD
Promethazine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000386	0.00165	CcSEcCtD
Promethazine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000386	0.00165	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—urinary bladder cancer	0.000382	0.00164	CcSEcCtD
Promethazine—Depression—Methotrexate—urinary bladder cancer	0.000381	0.00163	CcSEcCtD
Promethazine—Hypotension—Etoposide—urinary bladder cancer	0.00038	0.00163	CcSEcCtD
Promethazine—Pain—Cisplatin—urinary bladder cancer	0.00038	0.00163	CcSEcCtD
Promethazine—Dizziness—Thiotepa—urinary bladder cancer	0.000375	0.0016	CcSEcCtD
Promethazine—Asthma—Doxorubicin—urinary bladder cancer	0.000371	0.00159	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000366	0.00157	CcSEcCtD
Promethazine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000366	0.00157	CcSEcCtD
Promethazine—Somnolence—Etoposide—urinary bladder cancer	0.000362	0.00155	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—urinary bladder cancer	0.000358	0.00153	CcSEcCtD
Promethazine—Rash—Thiotepa—urinary bladder cancer	0.000357	0.00153	CcSEcCtD
Promethazine—Dermatitis—Thiotepa—urinary bladder cancer	0.000357	0.00153	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000357	0.00153	CcSEcCtD
Promethazine—Headache—Thiotepa—urinary bladder cancer	0.000355	0.00152	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—urinary bladder cancer	0.000354	0.00151	CcSEcCtD
Promethazine—Fatigue—Etoposide—urinary bladder cancer	0.000351	0.0015	CcSEcCtD
Promethazine—Jaundice—Epirubicin—urinary bladder cancer	0.000349	0.00149	CcSEcCtD
Promethazine—Constipation—Etoposide—urinary bladder cancer	0.000348	0.00149	CcSEcCtD
Promethazine—Pain—Etoposide—urinary bladder cancer	0.000348	0.00149	CcSEcCtD
Promethazine—Asthenia—Gemcitabine—urinary bladder cancer	0.000342	0.00146	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000339	0.00145	CcSEcCtD
Promethazine—Pruritus—Gemcitabine—urinary bladder cancer	0.000337	0.00144	CcSEcCtD
Promethazine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000335	0.00144	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000334	0.00143	CcSEcCtD
Promethazine—Pruritus—Fluorouracil—urinary bladder cancer	0.000331	0.00142	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000331	0.00142	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—urinary bladder cancer	0.000327	0.0014	CcSEcCtD
Promethazine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000326	0.0014	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—urinary bladder cancer	0.000322	0.00138	CcSEcCtD
Promethazine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00032	0.00137	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—urinary bladder cancer	0.00032	0.00137	CcSEcCtD
Promethazine—Asthenia—Cisplatin—urinary bladder cancer	0.000319	0.00136	CcSEcCtD
Promethazine—Dizziness—Fluorouracil—urinary bladder cancer	0.00031	0.00133	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000309	0.00132	CcSEcCtD
Promethazine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000304	0.0013	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000302	0.00129	CcSEcCtD
Promethazine—Rash—Gemcitabine—urinary bladder cancer	0.0003	0.00129	CcSEcCtD
Promethazine—Dermatitis—Gemcitabine—urinary bladder cancer	0.0003	0.00129	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—urinary bladder cancer	0.000299	0.00128	CcSEcCtD
Promethazine—Erythema—Methotrexate—urinary bladder cancer	0.000299	0.00128	CcSEcCtD
Promethazine—Headache—Gemcitabine—urinary bladder cancer	0.000298	0.00128	CcSEcCtD
Promethazine—ABCB1—lymph node—urinary bladder cancer	0.000297	0.00224	CbGeAlD
Promethazine—Rash—Fluorouracil—urinary bladder cancer	0.000295	0.00126	CcSEcCtD
Promethazine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000295	0.00126	CcSEcCtD
Promethazine—Headache—Fluorouracil—urinary bladder cancer	0.000293	0.00126	CcSEcCtD
Promethazine—Asthenia—Etoposide—urinary bladder cancer	0.000292	0.00125	CcSEcCtD
Promethazine—Pruritus—Etoposide—urinary bladder cancer	0.000288	0.00123	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000287	0.00123	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—urinary bladder cancer	0.000281	0.00121	CcSEcCtD
Promethazine—Rash—Cisplatin—urinary bladder cancer	0.00028	0.0012	CcSEcCtD
Promethazine—Dermatitis—Cisplatin—urinary bladder cancer	0.00028	0.0012	CcSEcCtD
Promethazine—Erythema—Epirubicin—urinary bladder cancer	0.000279	0.0012	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—urinary bladder cancer	0.000278	0.00119	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000277	0.00119	CcSEcCtD
Promethazine—Tension—Epirubicin—urinary bladder cancer	0.000274	0.00117	CcSEcCtD
Promethazine—Nervousness—Epirubicin—urinary bladder cancer	0.000271	0.00116	CcSEcCtD
Promethazine—Dizziness—Etoposide—urinary bladder cancer	0.000269	0.00115	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000269	0.00115	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—urinary bladder cancer	0.000267	0.00114	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000265	0.00114	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—urinary bladder cancer	0.000263	0.00113	CcSEcCtD
Promethazine—Convulsion—Methotrexate—urinary bladder cancer	0.000259	0.00111	CcSEcCtD
Promethazine—Erythema—Doxorubicin—urinary bladder cancer	0.000259	0.00111	CcSEcCtD
Promethazine—Agitation—Epirubicin—urinary bladder cancer	0.000257	0.0011	CcSEcCtD
Promethazine—Rash—Etoposide—urinary bladder cancer	0.000257	0.0011	CcSEcCtD
Promethazine—Dermatitis—Etoposide—urinary bladder cancer	0.000256	0.0011	CcSEcCtD
Promethazine—Headache—Etoposide—urinary bladder cancer	0.000255	0.00109	CcSEcCtD
Promethazine—Tension—Doxorubicin—urinary bladder cancer	0.000254	0.00109	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—urinary bladder cancer	0.000251	0.00108	CcSEcCtD
Promethazine—Syncope—Epirubicin—urinary bladder cancer	0.000251	0.00107	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—urinary bladder cancer	0.00025	0.00107	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000249	0.00106	CcSEcCtD
Promethazine—Palpitations—Epirubicin—urinary bladder cancer	0.000247	0.00106	CcSEcCtD
Promethazine—Confusional state—Methotrexate—urinary bladder cancer	0.000246	0.00105	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000246	0.00105	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000244	0.00104	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000244	0.00104	CcSEcCtD
Promethazine—Convulsion—Epirubicin—urinary bladder cancer	0.000242	0.00104	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000239	0.00102	CcSEcCtD
Promethazine—Agitation—Doxorubicin—urinary bladder cancer	0.000238	0.00102	CcSEcCtD
Promethazine—Anxiety—Epirubicin—urinary bladder cancer	0.000237	0.00102	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—urinary bladder cancer	0.000233	0.000996	CcSEcCtD
Promethazine—Syncope—Doxorubicin—urinary bladder cancer	0.000232	0.000993	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000231	0.000991	CcSEcCtD
Promethazine—Confusional state—Epirubicin—urinary bladder cancer	0.00023	0.000985	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—urinary bladder cancer	0.000228	0.000978	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000228	0.000977	CcSEcCtD
Promethazine—Oedema—Epirubicin—urinary bladder cancer	0.000228	0.000977	CcSEcCtD
Promethazine—Hypotension—Methotrexate—urinary bladder cancer	0.000228	0.000975	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000227	0.000973	CcSEcCtD
Promethazine—Shock—Epirubicin—urinary bladder cancer	0.000224	0.000961	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—urinary bladder cancer	0.000224	0.000959	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000223	0.000956	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—urinary bladder cancer	0.000223	0.000953	CcSEcCtD
Promethazine—Insomnia—Methotrexate—urinary bladder cancer	0.00022	0.000944	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—urinary bladder cancer	0.000219	0.000939	CcSEcCtD
Promethazine—Somnolence—Methotrexate—urinary bladder cancer	0.000217	0.000928	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000215	0.000922	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000214	0.000919	CcSEcCtD
Promethazine—Hypotension—Epirubicin—urinary bladder cancer	0.000213	0.000913	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—urinary bladder cancer	0.000213	0.000911	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000212	0.000907	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000211	0.000904	CcSEcCtD
Promethazine—Oedema—Doxorubicin—urinary bladder cancer	0.000211	0.000904	CcSEcCtD
Promethazine—Fatigue—Methotrexate—urinary bladder cancer	0.00021	0.0009	CcSEcCtD
Promethazine—Pain—Methotrexate—urinary bladder cancer	0.000208	0.000892	CcSEcCtD
Promethazine—Shock—Doxorubicin—urinary bladder cancer	0.000208	0.000889	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000207	0.000885	CcSEcCtD
Promethazine—Insomnia—Epirubicin—urinary bladder cancer	0.000206	0.000883	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000206	0.000882	CcSEcCtD
Promethazine—Somnolence—Epirubicin—urinary bladder cancer	0.000203	0.000868	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000201	0.00086	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000201	0.00086	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000198	0.000849	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—urinary bladder cancer	0.000197	0.000844	CcSEcCtD
Promethazine—Fatigue—Epirubicin—urinary bladder cancer	0.000197	0.000842	CcSEcCtD
Promethazine—Constipation—Epirubicin—urinary bladder cancer	0.000195	0.000835	CcSEcCtD
Promethazine—Pain—Epirubicin—urinary bladder cancer	0.000195	0.000835	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—urinary bladder cancer	0.000191	0.000817	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000188	0.000805	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—urinary bladder cancer	0.000188	0.000803	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000186	0.000795	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000183	0.000786	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—urinary bladder cancer	0.000182	0.000779	CcSEcCtD
Promethazine—Pain—Doxorubicin—urinary bladder cancer	0.00018	0.000773	CcSEcCtD
Promethazine—Constipation—Doxorubicin—urinary bladder cancer	0.00018	0.000773	CcSEcCtD
Promethazine—Asthenia—Methotrexate—urinary bladder cancer	0.000175	0.000749	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000174	0.000745	CcSEcCtD
Promethazine—Pruritus—Methotrexate—urinary bladder cancer	0.000172	0.000738	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000167	0.000714	CcSEcCtD
Promethazine—Asthenia—Epirubicin—urinary bladder cancer	0.000164	0.000701	CcSEcCtD
Promethazine—Pruritus—Epirubicin—urinary bladder cancer	0.000161	0.000691	CcSEcCtD
Promethazine—Dizziness—Methotrexate—urinary bladder cancer	0.000161	0.00069	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000156	0.000668	CcSEcCtD
Promethazine—Rash—Methotrexate—urinary bladder cancer	0.000154	0.000658	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—urinary bladder cancer	0.000153	0.000657	CcSEcCtD
Promethazine—Headache—Methotrexate—urinary bladder cancer	0.000153	0.000654	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—urinary bladder cancer	0.000151	0.000648	CcSEcCtD
Promethazine—Dizziness—Epirubicin—urinary bladder cancer	0.000151	0.000646	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—urinary bladder cancer	0.000149	0.000639	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000144	0.000618	CcSEcCtD
Promethazine—Rash—Epirubicin—urinary bladder cancer	0.000144	0.000616	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—urinary bladder cancer	0.000144	0.000615	CcSEcCtD
Promethazine—Headache—Epirubicin—urinary bladder cancer	0.000143	0.000612	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—urinary bladder cancer	0.00014	0.000598	CcSEcCtD
Promethazine—Rash—Doxorubicin—urinary bladder cancer	0.000133	0.00057	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000133	0.000569	CcSEcCtD
Promethazine—Headache—Doxorubicin—urinary bladder cancer	0.000132	0.000566	CcSEcCtD
Promethazine—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	1.06e-05	8.42e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—CDKN1A—urinary bladder cancer	1.05e-05	8.35e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—CDKN1A—urinary bladder cancer	1.05e-05	8.35e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	1.05e-05	8.34e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PTEN—urinary bladder cancer	1.05e-05	8.33e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PTEN—urinary bladder cancer	1.05e-05	8.33e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	1.05e-05	8.32e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MYC—urinary bladder cancer	1.03e-05	8.22e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EP300—urinary bladder cancer	1.03e-05	8.21e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EGFR—urinary bladder cancer	1.01e-05	8.04e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.01e-05	7.99e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—SRC—urinary bladder cancer	1e-05	7.99e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—CDKN1A—urinary bladder cancer	1e-05	7.97e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PTEN—urinary bladder cancer	1e-05	7.95e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PTEN—urinary bladder cancer	1e-05	7.95e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EP300—urinary bladder cancer	1e-05	7.95e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EP300—urinary bladder cancer	1e-05	7.95e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	9.91e-06	7.87e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	9.9e-06	7.87e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	9.88e-06	7.85e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	9.87e-06	7.85e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	9.84e-06	7.82e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	9.81e-06	7.8e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CREBBP—urinary bladder cancer	9.81e-06	7.8e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—SRC—urinary bladder cancer	9.72e-06	7.73e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—SRC—urinary bladder cancer	9.72e-06	7.73e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	9.72e-06	7.72e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CDKN1A—urinary bladder cancer	9.7e-06	7.71e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—CDKN1A—urinary bladder cancer	9.7e-06	7.71e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	9.69e-06	7.7e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	9.69e-06	7.7e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IGF1—urinary bladder cancer	9.69e-06	7.7e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PTEN—urinary bladder cancer	9.68e-06	7.69e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PTEN—urinary bladder cancer	9.68e-06	7.69e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EGFR—urinary bladder cancer	9.64e-06	7.66e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—urinary bladder cancer	9.61e-06	7.64e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	9.56e-06	7.6e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—EP300—urinary bladder cancer	9.54e-06	7.59e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EP300—urinary bladder cancer	9.54e-06	7.58e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	9.54e-06	7.58e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CREBBP—urinary bladder cancer	9.49e-06	7.54e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CREBBP—urinary bladder cancer	9.49e-06	7.54e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	9.48e-06	7.53e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	9.39e-06	7.46e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IGF1—urinary bladder cancer	9.37e-06	7.45e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IGF1—urinary bladder cancer	9.37e-06	7.45e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	9.37e-06	7.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	9.34e-06	7.42e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EGFR—urinary bladder cancer	9.33e-06	7.41e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EGFR—urinary bladder cancer	9.33e-06	7.41e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	9.33e-06	7.41e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	9.31e-06	7.4e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	9.31e-06	7.4e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—urinary bladder cancer	9.29e-06	7.39e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—urinary bladder cancer	9.29e-06	7.39e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—SRC—urinary bladder cancer	9.28e-06	7.37e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	9.28e-06	7.37e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.26e-06	7.36e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	9.25e-06	7.35e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EP300—urinary bladder cancer	9.23e-06	7.34e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EP300—urinary bladder cancer	9.23e-06	7.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	9.22e-06	7.32e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	9.19e-06	7.3e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	9.16e-06	7.28e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	9.16e-06	7.28e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	9.13e-06	7.26e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	9.12e-06	7.25e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	9.11e-06	7.24e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—SRC—urinary bladder cancer	8.98e-06	7.13e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—SRC—urinary bladder cancer	8.98e-06	7.13e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	8.97e-06	7.13e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	8.95e-06	7.11e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	8.92e-06	7.09e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	8.89e-06	7.07e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.89e-06	7.07e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	8.89e-06	7.06e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	8.88e-06	7.05e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	8.81e-06	7e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	8.81e-06	7e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EGFR—urinary bladder cancer	8.81e-06	7e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	8.81e-06	7e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	8.78e-06	6.98e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	8.74e-06	6.95e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	8.73e-06	6.93e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8.72e-06	6.93e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	8.7e-06	6.91e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	8.67e-06	6.89e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.65e-06	6.87e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	8.63e-06	6.86e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	8.61e-06	6.84e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	8.6e-06	6.83e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	8.59e-06	6.82e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	8.59e-06	6.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	8.59e-06	6.82e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	8.58e-06	6.82e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	8.56e-06	6.8e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—urinary bladder cancer	8.52e-06	6.77e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—urinary bladder cancer	8.52e-06	6.77e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	8.5e-06	6.75e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	8.49e-06	6.75e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	8.47e-06	6.73e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.46e-06	6.72e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	8.44e-06	6.71e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.44e-06	6.71e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	8.44e-06	6.71e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	8.42e-06	6.69e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	8.42e-06	6.69e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.41e-06	6.69e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	8.39e-06	6.67e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	8.39e-06	6.67e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.38e-06	6.66e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTEN—urinary bladder cancer	8.38e-06	6.66e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	8.37e-06	6.65e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	8.34e-06	6.62e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—urinary bladder cancer	8.32e-06	6.61e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—urinary bladder cancer	8.31e-06	6.61e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	8.31e-06	6.61e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.31e-06	6.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	8.31e-06	6.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	8.29e-06	6.59e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.28e-06	6.58e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	8.26e-06	6.57e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	8.22e-06	6.53e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—EP300—urinary bladder cancer	8.21e-06	6.53e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	8.18e-06	6.5e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	8.14e-06	6.47e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—urinary bladder cancer	8.13e-06	6.46e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	8.13e-06	6.46e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—urinary bladder cancer	8.11e-06	6.44e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—urinary bladder cancer	8.11e-06	6.44e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—urinary bladder cancer	8.05e-06	6.4e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—urinary bladder cancer	8.05e-06	6.4e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	8.05e-06	6.4e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—urinary bladder cancer	8.04e-06	6.39e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—urinary bladder cancer	8.04e-06	6.39e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	8.03e-06	6.38e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	8.01e-06	6.36e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—EP300—urinary bladder cancer	7.99e-06	6.35e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	7.98e-06	6.34e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	7.95e-06	6.32e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	7.95e-06	6.32e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	7.95e-06	6.32e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	7.9e-06	6.28e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	7.88e-06	6.26e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—urinary bladder cancer	7.87e-06	6.25e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—urinary bladder cancer	7.87e-06	6.25e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	7.83e-06	6.22e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	7.81e-06	6.21e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	7.79e-06	6.19e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	7.79e-06	6.19e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	7.78e-06	6.18e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	7.76e-06	6.17e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	7.74e-06	6.15e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—EP300—urinary bladder cancer	7.73e-06	6.14e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—EP300—urinary bladder cancer	7.73e-06	6.14e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	7.69e-06	6.11e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—urinary bladder cancer	7.68e-06	6.11e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	7.66e-06	6.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	7.54e-06	5.99e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	7.54e-06	5.99e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	7.49e-06	5.95e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	7.49e-06	5.95e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—urinary bladder cancer	7.45e-06	5.92e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—urinary bladder cancer	7.43e-06	5.91e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—urinary bladder cancer	7.43e-06	5.91e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.28e-06	5.79e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	7.26e-06	5.77e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—urinary bladder cancer	7.2e-06	5.72e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—urinary bladder cancer	7.2e-06	5.72e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	7.13e-06	5.67e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—urinary bladder cancer	7.07e-06	5.62e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	7.05e-06	5.6e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	7.02e-06	5.58e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	7.02e-06	5.58e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	7.02e-06	5.58e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	7.01e-06	5.57e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	7.01e-06	5.57e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	7e-06	5.56e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	6.98e-06	5.54e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	6.97e-06	5.54e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	6.95e-06	5.53e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	6.89e-06	5.47e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	6.87e-06	5.46e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	6.86e-06	5.45e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	6.86e-06	5.45e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	6.85e-06	5.44e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—urinary bladder cancer	6.84e-06	5.44e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—urinary bladder cancer	6.84e-06	5.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	6.82e-06	5.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	6.82e-06	5.42e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	6.82e-06	5.42e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.8e-06	5.41e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	6.8e-06	5.41e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	6.79e-06	5.4e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.79e-06	5.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	6.78e-06	5.39e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	6.78e-06	5.39e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	6.74e-06	5.35e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	6.72e-06	5.34e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EP300—urinary bladder cancer	6.68e-06	5.31e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	6.59e-06	5.23e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—urinary bladder cancer	6.53e-06	5.19e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—urinary bladder cancer	6.5e-06	5.16e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	6.48e-06	5.15e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	6.47e-06	5.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EP300—urinary bladder cancer	6.46e-06	5.14e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EP300—urinary bladder cancer	6.46e-06	5.14e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	6.45e-06	5.12e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	6.43e-06	5.11e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	6.36e-06	5.06e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.35e-06	5.05e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	6.35e-06	5.04e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—urinary bladder cancer	6.32e-06	5.02e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—urinary bladder cancer	6.32e-06	5.02e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—urinary bladder cancer	6.29e-06	5e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—urinary bladder cancer	6.29e-06	5e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—EP300—urinary bladder cancer	6.06e-06	4.81e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.98e-06	4.76e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.93e-06	4.71e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	5.85e-06	4.65e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—urinary bladder cancer	5.82e-06	4.63e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	5.76e-06	4.58e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	5.75e-06	4.57e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	5.73e-06	4.55e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	5.71e-06	4.54e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.71e-06	4.54e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	5.69e-06	4.53e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.66e-06	4.5e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	5.66e-06	4.49e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	5.64e-06	4.48e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—urinary bladder cancer	5.63e-06	4.48e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—urinary bladder cancer	5.63e-06	4.48e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	5.6e-06	4.45e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	5.51e-06	4.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	5.51e-06	4.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	5.51e-06	4.38e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	5.5e-06	4.37e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	5.48e-06	4.35e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	5.46e-06	4.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	5.41e-06	4.3e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	5.39e-06	4.29e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	5.38e-06	4.28e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	5.2e-06	4.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	5.2e-06	4.14e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—urinary bladder cancer	4.78e-06	3.8e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—urinary bladder cancer	4.63e-06	3.68e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—urinary bladder cancer	4.63e-06	3.68e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	4.57e-06	3.63e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	4.42e-06	3.52e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	4.42e-06	3.52e-05	CbGpPWpGaD
